{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T06:26:48Z","timestamp":1791354408825,"version":"4.3.1"},"reference-count":21,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2006,9,13]],"date-time":"2006-09-13T00:00:00Z","timestamp":1158105600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2006,9,13]],"date-time":"2006-09-13T00:00:00Z","timestamp":1158105600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,12]]},"DOI":"10.1111\/j.1365-2133.2006.07514.x","type":"journal-article","created":{"date-parts":[[2006,9,13]],"date-time":"2006-09-13T14:16:38Z","timestamp":1158156998000},"page":"1287-1292","source":"Crossref","is-referenced-by-count":81,"title":["<i>In situ<\/i>\n photoimmunotherapy: a tumour-directed treatment for melanoma"],"prefix":"10.1093","volume":"155","author":[{"given":"M.F.","family":"Naylor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.R.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.K.","family":"Teague","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.A.","family":"Perry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.E.","family":"Nordquist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2006,9,13]]},"reference":[{"key":"10.1111\/j.1365-2133.2006.07514.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"3635","DOI":"10.1200\/JCO.2001.19.16.3635","article-title":"Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma","volume":"19","author":"Balch","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1111\/j.1365-2133.2006.07514.x-BIB2|cit2","first-page":"275","article-title":"Malignant melanoma: a clinical review","volume":"63","author":"Brown","year":"1999","journal-title":"Cutis"},{"key":"10.1111\/j.1365-2133.2006.07514.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1002\/(SICI)1097-0142(20000315)88:6<1484::AID-CNCR29>3.0.CO;2-D","article-title":"A new American Joint Committee on Cancer staging system for cutaneous melanoma","volume":"88","author":"Balch","year":"2000","journal-title":"Cancer"},{"key":"10.1111\/j.1365-2133.2006.07514.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1097\/00008390-200502000-00013","article-title":"Melanoma of unknown primary: experience at Massachusetts General Hospital and Dana-Farber Cancer Institute","volume":"15","author":"Katz","year":"2005","journal-title":"Melanoma Res"},{"key":"10.1111\/j.1365-2133.2006.07514.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1002\/bjs.4610","article-title":"Management of in-transit metastases from cutaneous malignant melanoma","volume":"91","author":"Hayes","year":"2004","journal-title":"Br J Surg"},{"key":"10.1111\/j.1365-2133.2006.07514.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1002\/(SICI)1097-0215(19990531)81:5<808::AID-IJC23>3.0.CO;2-J","article-title":"Long-term tumor resistance induced by laser photo-immunotherapy","volume":"81","author":"Chen","year":"1999","journal-title":"Int J Cancer"},{"key":"10.1111\/j.1365-2133.2006.07514.x-BIB7|cit7","first-page":"459","article-title":"Antitumor immunity induced by laser immunotherapy and its adoptive transfer","volume":"61","author":"Chen","year":"2001","journal-title":"Cancer Res"},{"key":"10.1111\/j.1365-2133.2006.07514.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1002\/ijc.11501","article-title":"Induced antitumor immunity against DMBA-4 metastatic mammary tumors in rats using laser immunotherapy","volume":"107","author":"Chen","year":"2003","journal-title":"Int J Cancer"},{"key":"10.1111\/j.1365-2133.2006.07514.x-BIB9|cit9","first-page":"555","article-title":"Topical imiquimod treatment of a cutaneous melanoma metastasis","volume":"43","author":"Steinmann","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2006.07514.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1111\/j.0007-0963.2004.05898.x","article-title":"In vivo and in situ modulation of the expression of genes involved in metastasis and angiogenesis in a patient treated with topical imiquimod for melanoma skin metastases","volume":"150","author":"Hesling","year":"2004","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2006.07514.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1007\/s00105-003-0625-z","article-title":"Imiquimod, pegylated interferon-alpha-2b and interleukin-2 in the treatment of cutaneous melanoma metastases","volume":"55","author":"Loquai","year":"2004","journal-title":"Hautarzt"},{"key":"10.1111\/j.1365-2133.2006.07514.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1159\/000068901","article-title":"Management of cutaneous locoregional recurrences of melanoma: a new therapeutic perspective with imiquimod","volume":"206","author":"Vereecken","year":"2003","journal-title":"Dermatology"},{"key":"10.1111\/j.1365-2133.2006.07514.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1159\/000063904","article-title":"Imiquimod, a topical immune response modifier, in the treatment of cutaneous metastases of malignant melanoma","volume":"205","author":"Bong","year":"2002","journal-title":"Dermatology"},{"key":"10.1111\/j.1365-2133.2006.07514.x-BIB14|cit14","first-page":"244","article-title":"Locoregional cutaneous metastases of malignant melanoma and their management","volume":"30","author":"Wolf","year":"2004","journal-title":"Dermatol Surg"},{"key":"10.1111\/j.1365-2133.2006.07514.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/j.0105-2896.2004.00144.x","article-title":"Modulating vaccine responses with dendritic cells and toll-like receptors","volume":"199","author":"Pulendran","year":"2004","journal-title":"Immunol Rev"},{"key":"10.1111\/j.1365-2133.2006.07514.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.4049\/jimmunol.172.4.2431","article-title":"Haemophilus influenzae type 6-outer mebrane protein complex glycoconjugate vaccine induces cytokine production by engaging human toll-lite receptor (TLR2) and requires the presence of TLR2 for optimal immunogenicity","volume":"2","author":"Latz","year":"2004","journal-title":"J Immunol"},{"key":"10.1111\/j.1365-2133.2006.07514.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1007\/s10875-004-6244-3","article-title":"CPG 7909, an immunostimulatory TLR9 agonist oligodeoxynucleotide, as adjuvant to Engerix-B HBV vaccine in healthy adults: a double-blind phase I\/II study","volume":"24","author":"Cooper","year":"2004","journal-title":"J Clin Immunol"},{"key":"10.1111\/j.1365-2133.2006.07514.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.vaccine.2004.07.014","article-title":"Co-administration of CpG oligonucleotides enhances the late affinity maturation process of human anti-hepatitis B vaccine response","volume":"23","author":"Siegrist","year":"2004","journal-title":"Vaccine"},{"key":"10.1111\/j.1365-2133.2006.07514.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1517\/14712598.4.7.1129","article-title":"Taking a toll on human disease: toll-like receptor 4 agonists as vaccine adjuvants and monotherapeutic agents","volume":"4","author":"Baldridge","year":"2004","journal-title":"Expert Opin Biol Ther"},{"key":"10.1111\/j.1365-2133.2006.07514.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/j.0022-202X.2004.23208.x","article-title":"CpG motifs are efficient adjuvants for DNA cancer vaccines","volume":"123","author":"Schneeberger","year":"2004","journal-title":"J Invest Dermatol"},{"key":"10.1111\/j.1365-2133.2006.07514.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"79","DOI":"10.2165\/00063030-200418020-00002","article-title":"Immunological foundations to the quest for new vaccine adjuvants","volume":"18","author":"Burdin","year":"2004","journal-title":"BioDrugs"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2133.2006.07514.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2133.2006.07514.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1365-2133.2006.07514.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T14:18:54Z","timestamp":1676384334000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/155\/6\/1287\/6637357"}},"subtitle":["ISPI: a tumour-directed treatment for melanoma"],"short-title":[],"issued":{"date-parts":[[2006,9,13]]},"references-count":21,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2006,12]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2133.2006.07514.x","archive":["Portico"],"relation":{},"ISSN":["0007-0963"],"issn-type":[{"value":"0007-0963","type":"print"}],"subject":[],"published":{"date-parts":[[2006,9,13]]}}}